Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic and Translational - In vitro and In vivo Oncology

Immuno-PET/CT evaluation of two CAIX VHH-based [89Zr]Zr(IV) radioimmunoconjugates for specific targeting of hypoxic solid tumor areas in colon rectal cancer: a step closer to radioimmunotherapy.

Maria de Guadalupe Jaraquemada-Pelaez, Helen Merkens, Lily Li, Mathilde Ligeour, Wing Sum Lau, Pauline Ng, Nadine Colpo, Lei Wang, Joseph Lau, Mehdi Arbabi, Anne Lenferink, Nazanin Rohani-Larijani and Francois Benard
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241865;
Maria de Guadalupe Jaraquemada-Pelaez
1British Columbia Cancer Agency (BCCA)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Merkens
2BC Cancer Research Centre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lily Li
3BC Cancer Research Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathilde Ligeour
4bc cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wing Sum Lau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pauline Ng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadine Colpo
5BC Cancer - Vancouver
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Wang
6University of British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Lau
6University of British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehdi Arbabi
7NRC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Lenferink
8National Research Council of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nazanin Rohani-Larijani
9National Research Council, Human Health Therapeutics Research Center, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Benard
10BC Cancer Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Immuno-PET/CT evaluation of two CAIX VHH-based [89Zr]Zr(IV) radioimmunoconjugates for specific targeting of hypoxic solid tumor areas in colon rectal cancer: a step closer to radioimmunotherapy.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Immuno-PET/CT evaluation of two CAIX VHH-based [89Zr]Zr(IV) radioimmunoconjugates for specific targeting of hypoxic solid tumor areas in colon rectal cancer: a step closer to radioimmunotherapy.
Maria de Guadalupe Jaraquemada-Pelaez, Helen Merkens, Lily Li, Mathilde Ligeour, Wing Sum Lau, Pauline Ng, Nadine Colpo, Lei Wang, Joseph Lau, Mehdi Arbabi, Anne Lenferink, Nazanin Rohani-Larijani, Francois Benard
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241865;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Immuno-PET/CT evaluation of two CAIX VHH-based [89Zr]Zr(IV) radioimmunoconjugates for specific targeting of hypoxic solid tumor areas in colon rectal cancer: a step closer to radioimmunotherapy.
Maria de Guadalupe Jaraquemada-Pelaez, Helen Merkens, Lily Li, Mathilde Ligeour, Wing Sum Lau, Pauline Ng, Nadine Colpo, Lei Wang, Joseph Lau, Mehdi Arbabi, Anne Lenferink, Nazanin Rohani-Larijani, Francois Benard
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241865;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Evaluating ΔFFNP-PET as an imaging biomarker of estrogen receptor α (ERα) functional status in preclinical models of ERα+ breast cancer with ESR1 mutations
  • A20 downregulation drives metabolic diversity in lung adenocarcinomas - insights from multi-modal molecular imaging
  • PET Imaging Study of 68Ga-Labeled GZP Probe for Diagnosis and Therapeutic Monitoring of Acute-Graft-Versus-Host Disease (aGVHD) in Mice
Show more Oncology, Basic and Translational - In vitro and In vivo Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire